These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 35834311)

  • 1. Antibiotic-Derived Radiotracers for Positron Emission Tomography: Nuclear or "Unclear" Infection Imaging?
    Gouws AC; Kruger HG; Gheysens O; Zeevaart JR; Govender T; Naicker T; Ebenhan T
    Angew Chem Int Ed Engl; 2022 Nov; 61(45):e202204955. PubMed ID: 35834311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
    Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
    Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on PET radiopharmaceuticals: life beyond fluorodeoxyglucose.
    Shiue CY; Welch MJ
    Radiol Clin North Am; 2004 Nov; 42(6):1033-53, viii. PubMed ID: 15488556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiopharmaceuticals in positron emission tomography: present situation and future perspectives.
    Olivas Arroyo C
    Radiologia; 2016; 58(6):468-480. PubMed ID: 27592111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Team for Unique Molecular Imaging Based in South Africa.
    Angew Chem Int Ed Engl; 2023 Aug; 62(31):e202305726. PubMed ID: 37306614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of (18)F-labeled radiotracers for neuroreceptor imaging with positron emission tomography.
    Brust P; van den Hoff J; Steinbach J
    Neurosci Bull; 2014 Oct; 30(5):777-811. PubMed ID: 25172118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotracers for positron emission tomography imaging.
    Gillings N
    MAGMA; 2013 Feb; 26(1):149-58. PubMed ID: 23242769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of a PET/SPECT Radiopharmaceutical in Oncology.
    Pisaneschi F; Viola NT
    Mol Imaging Biol; 2022 Feb; 24(1):1-7. PubMed ID: 34542804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond monoamines: I. Novel targets and radiotracers for Positron emission tomography imaging in psychiatric disorders.
    Lopresti BJ; Royse SK; Mathis CA; Tollefson SA; Narendran R
    J Neurochem; 2023 Feb; 164(3):364-400. PubMed ID: 35536762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrazoles as Key Scaffolds for the Development of Fluorine-18-Labeled Radiotracers for Positron Emission Tomography (PET).
    Gomes PMO; Silva AMS; Silva VLM
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32283680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moving into the next era of PET myocardial perfusion imaging: introduction of novel
    Werner RA; Chen X; Rowe SP; Lapa C; Javadi MS; Higuchi T
    Int J Cardiovasc Imaging; 2019 Mar; 35(3):569-577. PubMed ID: 30334228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new?
    Vallabhajosula S; Solnes L; Vallabhajosula B
    Semin Nucl Med; 2011 Jul; 41(4):246-64. PubMed ID: 21624560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted nuclear imaging of breast cancer: status of radiotracer development and clinical applications.
    Kong FL; Kim EE; Yang DJ
    Cancer Biother Radiopharm; 2012 Mar; 27(2):105-12. PubMed ID: 21877909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of structural alterations on the radiopharmacological profile of
    Tietz O; Marshall A; Bergman C; Wuest M; Wuest F
    Nucl Med Biol; 2018; 62-63():9-17. PubMed ID: 29800798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomographic imaging in drug discovery.
    Ghosh KK; Padmanabhan P; Yang CT; Ng DCE; Palanivel M; Mishra S; Halldin C; Gulyás B
    Drug Discov Today; 2022 Jan; 27(1):280-291. PubMed ID: 34332093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [PET imaging for better understanding of normal and pathological neurotransmission].
    Zimmer L
    Biol Aujourdhui; 2019; 213(3-4):109-120. PubMed ID: 31829931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPECT and PET Radiotracers in Renal Imaging.
    Werner RA; Pomper MG; Buck AK; Rowe SP; Higuchi T
    Semin Nucl Med; 2022 Jul; 52(4):406-418. PubMed ID: 35058040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.